Heart Disease Trial, Recruiting NCT07296081 Sponsor: University of Coimbra Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07296081
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who have signs and symptoms of heart failure
  • People who fall into one of two heart conditions: (1) those with a preserved pumping function of the heart (at least 50%), along with evidence of the heart not relaxing properly, elevated heart-related markers in the blood, and a diagnosis of hypertrophic cardiomyopathy (a thickened heart muscle) confirmed by imaging and genetic testing showing a sarcomere gene mutation; OR (2) those with a reduced pumping function of the heart (40% or less), along with an enlarged heart confirmed by imaging that is not fully explained by other causes
  • People who have had a heart ultrasound (echocardiogram) within the past 3 months
  • People who have had a cardiac MRI scan within the past 3 months
  • People who have had a coronary angiogram or CT coronary angiogram within the past 6 months showing normal coronary arteries

Who may not be able to join:

  • People who are unable to give informed consent to participate
  • People who are unable to lie flat on their back
  • People whose heart or blood pressure is currently unstable
  • People who experience claustrophobia (fear of enclosed spaces)
  • People with significantly reduced kidney function (confirm with trial site)
  • People who are pregnant or breastfeeding
  • People who have had a cancer diagnosis within the past 5 years
  • People with significant disease affecting the heart valves
  • People with significant narrowing or blockage of the coronary arteries
  • People with moderately or severely high blood pressure (Grade 2 or 3 hypertension)
  • People who have an implanted heart device, such as a pacemaker or defibrillator
  • People who have been hospitalised for heart failure within the past 30 days

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +351239400400

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Coimbra
Registry
ClinicalTrials.gov
Start date
17 November 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇵🇹 Portugal

Primary endpoints

68Ga-FAPI uptake

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov